Drugs Made In America Acquisition II Corp. Unit
DMIIU - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$649.1M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $649.10 Million |
|---|---|
| Enterprise Value | $649.38 Million |
| Earnings per Share | $- |
| Beta | 0.06 |
| Outstanding Shares | - |
Return
| Return on Equity | 2.62% |
|---|---|
| Return on Assets | 2.53% |
| Return on Invested Capital | -0.28% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -448.67 |
| Enterprise Value to Net Income | 49 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Drugs Made In America Acquisition II Corp. Ordinary Shares
2 employees
CEO: Roger Bendelac
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a rec...